Genexine Inc Asset Resilience Ratio

Latest as of September 2025: 3.45%

Genexine Inc asset resilience ratio. Genexine Inc (095700) has an Asset Resilience Ratio of 3.45% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Genexine Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩12.65 Billion

≈ $8.57 Million USD Cash + Short-term Investments

Total Assets

₩366.23 Billion

≈ $248.19 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Genexine Inc (2009–2024)

Asset resilience ratio of Genexine Inc from 2009 to 2024. This chart shows how Genexine Inc's Asset Resilience Ratio has changed over time. Read Genexine Inc total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Genexine Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Genexine Inc.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩12.65 Billion	3.45%
Total Liquid Assets	₩12.65 Billion	3.45%

Asset Resilience Insights

Limited Liquidity: Genexine Inc maintains only 3.45% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Genexine Inc Industry Peers by Asset Resilience Ratio

Compare Genexine Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Chengdu Easton Biopharmaceuticals Co Ltd SHG:688513	Biotechnology	35.16%
China Resources Boya Bio pharmaceutical Group Co Ltd SHE:300294	Biotechnology	23.15%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Achieve Life Sciences Inc F:SP4P	Biotechnology	3.60%

Genexine Inc Asset Resilience Ratio by Year (2009–2024)

Genexine Inc asset resilience ratio by year from 2009 to 2024. The table below shows the annual Asset Resilience Ratio data for Genexine Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	9.30%	₩32.08 Billion ≈ $21.74 Million	₩345.04 Billion ≈ $233.83 Million	-7.83pp
2023-12-31	17.12%	₩64.48 Billion ≈ $43.70 Million	₩376.59 Billion ≈ $255.21 Million	+11.48pp
2022-12-31	5.64%	₩21.94 Billion ≈ $14.87 Million	₩388.78 Billion ≈ $263.47 Million	+1.28pp
2021-12-31	4.36%	₩27.80 Billion ≈ $18.84 Million	₩636.86 Billion ≈ $431.59 Million	+3.24pp
2020-12-31	1.12%	₩6.71 Billion ≈ $4.55 Million	₩596.91 Billion ≈ $404.52 Million	-21.91pp
2019-12-31	23.04%	₩82.52 Billion ≈ $55.92 Million	₩358.18 Billion ≈ $242.73 Million	-7.37pp
2018-12-31	30.41%	₩113.97 Billion ≈ $77.24 Million	₩374.81 Billion ≈ $254.00 Million	+31.37pp
2017-12-31	-0.96%	₩-1.35 Billion ≈ $-917.17K	₩140.73 Billion ≈ $95.37 Million	-18.49pp
2016-12-31	17.52%	₩34.82 Billion ≈ $23.60 Million	₩198.71 Billion ≈ $134.66 Million	-7.73pp
2012-12-31	25.25%	₩16.00 Billion ≈ $10.85 Million	₩63.38 Billion ≈ $42.95 Million	+5.18pp
2011-12-31	20.07%	₩7.86 Billion ≈ $5.33 Million	₩39.19 Billion ≈ $26.56 Million	-17.18pp
2010-12-31	37.25%	₩14.03 Billion ≈ $9.51 Million	₩37.67 Billion ≈ $25.53 Million	-17.50pp
2009-12-31	54.75%	₩23.42 Billion ≈ $15.87 Million	₩42.78 Billion ≈ $28.99 Million	--

pp = percentage points

About Genexine Inc

KQ:095700 Korea Biotechnology

Market Cap

$65.96 Million

₩97.33 Billion KRW

Market Cap Rank

#20646 Global

#1158 in Korea

Share Price

₩2140.00

Change (1 day)

-0.93%

52-Week Range

₩2140.00 - ₩7100.00

All Time High

₩131402.78